arrow
S

Suzanne E. Schindler

Washington University School of Medicine
H指数:46
被引数:8,049

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Exploring healthy aging through preclinical Alzheimer disease in the Knight Alzheimer Research Imaging dataset

通过Knight阿尔茨海默病研究影像数据集探索轻度认知障碍中的健康老龄化

2026-10-200
OAAI
Tau-PET and CSF MTBR-tau243 comparisons validate increased tau aggregation in females

Tau-PET和CSF MTBR-tau243比较证实女性中tau聚集增加

2026-05-270
OAAI
Low overlap of plasma and CSF protein quantitative trait loci affects protein discovery for neurological disease

血浆和脑脊液蛋白质数量性状位点的低重叠影响神经疾病的蛋白质发现

2026-04-290
PRE
GPND-AI NULISA: A 15-Protein AI classifier for diagnosis and co-pathology profiling across neurodegenerative diseases

GPND-AI NULISA:一种用于神经退行性疾病诊断和共病理特征分析的15蛋白AI分类器

2026-04-280
OAAI
GWAS meta-analysis of cerebrospinal fluid Alzheimer’s biomarkers reveals loci regulating lipids, brain volume and autophagy

脑脊液阿尔茨海默病生物标志物的GWAS荟萃分析揭示了调控脂质、脑容量和自噬的基因位点

2026-04-210
OAAI
Trajectories of plasma and CSF MTBR-tau243 and phosphorylated-tau species across the Alzheimer’s disease continuum

血浆和脑脊液中MTBR-tau243及磷酸化-tau蛋白物种在阿尔茨海默病连续谱中的轨迹

2026-04-090
OAAI
Predicting onset of symptomatic Alzheimerʼs disease with plasma p-tau217 clocks

预测症状性阿尔茨海默病的血浆p-tau217时钟

2026-02-190
OA
Plasma biomarkers in neuropsychiatric syndromes: A narrative review

神经精神综合征中的血浆生物标志物:一篇叙事性综述

2025-11-240
OA
High-sensitivity plasma proteomics reveals disease-specific signatures and predictive biomarkers of Alzheimer’s disease phenotypes in a large mixed-dementia cohort

高灵敏度血浆蛋白质组学揭示大型混合痴呆队列中阿尔茨海默病表型的疾病特异性标志物和预测性生物标志物

2025-11-190
OAAI
Blood-based biomarkers for detecting Alzheimer's disease pathology in cognitively impaired individuals within specialized care settings: A systematic review and meta-analysis

血液生物标志物用于检测认知障碍个体在专业护理环境中的阿尔茨海默病病理:一项系统评价和荟萃分析

2025-11-050
OAAI
Cerebrospinal fluid proteomic signatures in cognitively normal individuals identify distinct clusters linked to neurodegeneration

认知正常个体脑脊液蛋白质组学特征可识别与神经退行性变相关的不同集群

2025-10-140
PRE
Reference proteins to improve Core 1 and Core 2 Alzheimer’s disease CSF and plasma biomarkers

参考蛋白质以改善核心1型和核心2型阿尔茨海默病脑脊液和血浆生物标志物

Brain
IF11.7
2025-10-060
OAAI
New landscape of the diagnosis of Alzheimer's disease

阿尔茨海默病诊断的新格局

2025-09-220
OAAI
Age-related amyloid beta dynamics modeled with the generalized additive model for location, scale, and shape (GAMLSS) across diverse populations: Cross-sectional trajectories and longitudinal validation

基于位置-尺度-形状广义加性模型(GAMLSS)对多人群年龄相关淀粉样蛋白β动力学进行建模:横断面轨迹与纵向验证

2025-09-100
OAAI
Blood phosphorylated tau for the diagnosis of Alzheimer's disease: a systematic review and meta-analysis

血磷酸化tau蛋白用于阿尔茨海默病的诊断:一项系统评价和荟萃分析

2025-08-130
PRE
Person-specific digital measurements of air pollutant exposure and biomarkers of Alzheimer's disease: Findings from a pilot study

个体特异性空气污染物暴露的数字测量与阿尔茨海默病生物标志物:一项试点研究的结果

2025-07-270
PRE
Baseline and longitudinal changes in cortical thickness and hippocampal volume predict cognitive decline

基线及纵向皮质厚度和海马体积变化可预测认知衰退

2025-07-170
PRE